Navigation Links
Experimental Alzheimer's Drug Shows Promise
Date:4/17/2008

Analysis of early study found cognitive function improved in patients

THURSDAY, April 17 (HealthDay News) -- A new analysis of a study on an experimental Alzheimer's drug reinforces the notion that the compound is broadly effective at improving the cognitive function of mild to moderate Alzheimer's patients.

A second analysis of the trial on the medication, known as Dimebon, also reveals that by improving the Alzheimer's patients' ability to perform daily tasks, the drug shaves off almost an hour a day in the amount of time the average caregiver must attend to his or her patient.

The twin observations raise hope for a new and improved therapy to address both the symptoms and the underlying mechanisms driving a disease that the Alzheimer's Association says currently affects more than 5 million Americans.

"The broad context is that there are treatments available that treat Alzheimer's symptoms, but do not slow the disease down or prevent it," explained Steven H. Ferris, director of the Alzheimer's Disease Center at New York University. "So, we really need drugs that are more potent and safe and that actually slow the disease down."

"And this drug has that potential," he said. "It still needs more research -- which is going to happen. But, so far, it really looks like it might have a better effect than existing drugs and also a better side effect profile."

Ferris is expected to discuss the new research on Dimebon on Thursday at the American Academy of Neurology annual meeting, in Chicago.

He pointed out, however, that he played no role of any kind in initial analysis of a recently completed yearlong study that had looked into the drug's prospects.

Ferris describes his current connection to the Dimebon study as that of a paid "external scientific advisory board" member to drug maker Medivation Inc., engaged in helping the company interpret the findings to date while moving forwar
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2 3

Related medicine news :

1. Experimental drug shows promise in treating certain lymphomas
2. Experimental Cancer Vaccines Show Promise
3. Gourmetceuticals Presents Findings on Science You Can Eat at Experimental Biology 2008
4. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
5. Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
6. 52 minority scientists receive travel fellowships to Experimental Biology 2008
7. Experimental Biology 2008 Todays Research: Tomorrows Health, April 5-9
8. Experimental Vaccine Halts Prostate Cancer in Mice
9. Experimental technique at GUMC offers real-time analysis of breast cancer biopsies
10. Experimental Drug Fights Prostate Cancer
11. Experimental Drug Fails Against Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Alzheimer's Drug Shows Promise
(Date:5/21/2013)... Mass. (PRWEB) May 21, 2013 Dimensional ... today announced that Western Maryland Health System, ... be using The Diver Solution™ (Diver) to help it ... is the first customer to purchase Diver through Dimensional ... , Like most hospitals, Western Maryland has massive ...
(Date:5/21/2013)... NY (PRWEB) May 21, 2013 Tools4ever, ... solutions, has made its Self Service Reset Password Management ... SSRPM, employees can now use the service on mobile ... that end users can easily reset their Windows passwords ... set of questions correctly, the user may then reset ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...
(Date:5/21/2013)... physical activity appears to be an independent predictor ... pulmonary disease (COPD) will end up being hospitalized, ... in Connecticut. The study also corroborates an earlier ... an increased incidence of hospitalizations among patients with ... be presented at the ATS 2013 International Conference. ...
(Date:5/21/2013)... 2013 Barbara Michels, author of “ ... over 50 years of experience in the world of ... both her mom and dad to Alzheimer’s disease ... volunteer with the New Mexico Chapter of the Alzheimer’s ... and insight into the many challenges caregivers experience. Through ...
Breaking Medicine News(10 mins):Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3Health News:Exercise levels may predict hospitalizations in COPD population 2Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 2Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 3Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 4
... Accelerated growth of tumors seen in mouse study , , ... in the inorganic phosphates found in many natural and ... rats, South Korean researchers report. , "Our study suggests ... for lung cancer treatment as well as prevention," Myung-Haing ...
... among those whose families don,t accept them , , MONDAY, ... families rejected them when they were younger are more ... use and suicide attempts, new research suggests. , The ... a child,s sexuality directly causes problems later in life. ...
... high-fat diet can not only lead to overweight because ... balance of circadian rhythms everyone,s 24-hour biological clock, ... The biological clock regulates the expression and/or activity of ... the clock can lead to such phenomena as hormone ...
... Second Harvest Heartland, the,Upper Midwest,s largest hunger relief ... General Mills and NBC,s "The Biggest Loser.",Through the ... dieters,in Minnesota and western Wisconsin pledge to lose ... cents to Second Harvest Heartland -- enough to ...
... bean plant Ricinus communis is considered one of the ... tissue damage and inflammation and can result in death. ... of castor beans whereby the toxin is released after ... severe gastrointestinal damage with symptoms and death due to ...
... for the relief of fever, headaches, and other minor ... are well documented and acetaminophen is accepted to be ... of short-term, especially high-dose NSAID and acetaminophen use have ... be published on November 21 , 2008 in the ...
Cached Medicine News:Health News:Food Phosphates Might Spur Lung Cancer 2Health News:Food Phosphates Might Spur Lung Cancer 3Health News:Rejection of Gay Teens Linked to Later Troubles 2Health News:Rejection of Gay Teens Linked to Later Troubles 3Health News:Another reason to avoid high-fat diet -- it can disrupt our biological clock 2Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 2Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 3Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 4Health News:Acute gastric injury due to high-dose analgesics? 2
(Date:5/21/2013)... MOUNTAIN VIEW, Calif. , May 21, 2013 /PRNewswire/ ... Brazil , Russia , ... (BRIC) are realizing there are no shortcuts.  This ... especially in the United States.  Companies must change the ... establishing value, customizing to local needs, and building regional ...
(Date:5/21/2013)... -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: ... cell based therapies for various personal applications, announced that ... CEO, will be presenting at the Marcum MicroCap Conference.   ... Thursday, May 30, 2013 at the Grand Hyatt Hotel, ... City.  Mr. Weinreb,s presentation will take place at 2:30 ...
(Date:5/21/2013)... 21, 2013  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization ... acute and breakthrough pain, today announced top-line ... 3 study of its investigational sublingual Sufentanil ... the primary efficacy endpoint was achieved.  The ...
Breaking Medicine Technology:Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
... Pharmaceutical and healthcare market research company ... report, " Consumer Online Health Video : ... consumer demand for online health video and the impact ... health video has increased significantly among U.S. consumers online ...
... U.S. hospitals today reported significant progress in the fight ... and presented by clinicians from St. Joseph,s Mercy Hospital ... and the VA Medical Center in Seattle showed that ... some 62,500 hospital patients nationwide. (Logo: ...
Cached Medicine Technology:New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format 2Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections 2Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections 3Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections 4
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... reduces joint instability without disturbing hand ... comfortable and easy for users to ... and Robert V. Sypher Jr., MD, ... response to patients' complaints of discomfort ...
... The ThumSaver MP stabilizes the MP joint and the ... to reduce subluxation of both of the thumb joints. ... to eliminate pain, but who need maximum mobility for ... base of the thumb and for those with pain ...
... thumb splint is molded from rigid plastic in ... application and wearing comfort. The uniquely sculpted ... fingers and preserves maximum function of the hand. ... DeQuervain's Tendonitis, strains and sprains of the MCP ...
Medicine Products: